Long-term use of tirzepatide shows sustained and significant weight loss in adults with overweight or obesity.

(Nasdaq: GCTK) (“Glucotrack” or the “Company”), a medical device company focused on the design, development, and commercialization of novel technologies for people with diabetes, today announced that ...

A pair of studies show that Zepbound can help adults with obesity and overweight achieve sustained and meaningful weight loss ...

A once-weekly dose of tirzepatide (Mounjaro) can lead to significant, sustained weight loss for up to 3 years in adults with ...

Glucotrack (Nasdaq:GCTK) announced today that it intends to participate in a bionic pancreas initiative in Europe.

For adults struggling with weight, a weekly injection of tirzepatide offers real hope. Recent findings presented at the ...

Once-weekly treatment with tirzepatide can produce clinically meaningful and sustained weight loss for at least three years ...

Taking tirzepatide drug once a week may produce clinically meaningful and sustained weight loss for at least 3 years in adults with overweight or obesity who do not have diabetes, according to new ...

Despite the 2016 moratorium, illegal logging continues in Albania, fueled by corruption, weak law enforcement, and European ...

It's probably safe to say that weight-loss drugs aren't going anywhere any time soon. According to the most recent data, six percent of American adults, or roughly 16 million people, take such ...

Satellite data and artificial intelligence, researchers have mapped two crucial forest fire risk indicators—canopy base height (CBH) and canopy bulk ...

More than 300 scholars and professionals from around the world have signed a statement condemning the Vatican’s complicity in legitimizing Azerbaijan’s cultural erasure of Armenian Church history and ...